Desipramine and Some Other Antidepressant Drugs Decrease the Major Norepinephrine Metabolite 3,4-dihydroxyphenylglycol-sulphate in the Rat Brain

Overview

Journal Naunyn Schmiedebergs Arch Pharmacol

Specialty Pharmacology

Date 1977 Oct 25

PMID 593431

Citations 6

Authors

M Nielsen

C Braestrup

Affiliations

Soon will be listed here.

Citing Articles

The role of the central noradrenergic system in behavioral inhibition.

Stone E, Lin Y, Sarfraz Y, Quartermain D Brain Res Rev. 2011; 67(1-2):193-208.

PMID: 21315760 PMC: 3101301. DOI: 10.1016/j.brainresrev.2011.02.002.

Chronic and acute administration of typical and atypical antidepressants on activity of brain noradrenaline systems in the rat thiopentone anaesthesia model.

Mason S, Angel A Psychopharmacology (Berl). 1984; 84(3):304-9.

PMID: 6440174 DOI: 10.1007/BF00555203.

Behavioural evidence that chronic treatment with the antidepressant desipramine causes reduced functioning of brain noradrenaline systems.

Mason S, Angel A Psychopharmacology (Berl). 1983; 81(1):73-7.

PMID: 6415734 DOI: 10.1007/BF00439277.

Thyrotropin releasing hormone: neurochemical evidence for the potentiation of imipramine effects on the metabolism and uptake of brain catecholamines.

Rastogi R, Singhal R, Lapierre Y Psychopharmacology (Berl). 1980; 72(1):85-91.

PMID: 6110219 DOI: 10.1007/BF00433811.

Behavioral, biochemical, and blood pressure responses to alprazolam in healthy subjects: interactions with yohimbine.

Charney D, Breier A, Jatlow P, Heninger G Psychopharmacology (Berl). 1986; 88(2):133-40.

PMID: 3081923 DOI: 10.1007/BF00652229.

References

Squires R . Effects of noradrenaline pump blockers on its uptake by synaptosomes from several brain regions; additional evidence for dopamine terminals in the frontal cortex. J Pharm Pharmacol. 1974; 26(5):364-7. DOI: 10.1111/j.2042-7158.1974.tb09292.x. View

Nielsen M . The influence of desipramine and amitriptyline on the accumulation of [3-H]noradrenaline and its two major metabolites formed from [3-H]tyrosine in the rat brain. J Pharm Pharmacol. 1975; 27(3):207-9. View

Nielsen M . Estimation of noradrenaline and its major metabolites synthesized from [3H] tyrosine in the rat brain. J Neurochem. 1976; 27(2):493-500. DOI: 10.1111/j.1471-4159.1976.tb12273.x. View

Schanberg S, Schildkraut J, Breese G, Kopin I . Metabolism of normetanephrine-H3 in rat brain--identification of conjugated 3-methoxy-4-hydrophenylglycol as the major metabolite. Biochem Pharmacol. 1968; 17(2):247-54. PMC: 3051363. DOI: 10.1016/0006-2952(68)90330-4. View

Brodie B, Costa E, Groppetti A, Matsumoto C . Interaction between desipramine, tyramine, and amphetamine at adrenergic neurones. Br J Pharmacol. 1968; 34(3):648-58. PMC: 1703529. DOI: 10.1111/j.1476-5381.1968.tb08494.x. View

Glowinski J, Axelrod J . INHIBITION OF UPTAKE OF TRITIATED-NORADRENALINE IN THE INTACT RAT BRAIN BY IMIPRAMINE AND STRUCTURALLY RELATED COMPOUNDS. Nature. 1964; 204:1318-9. DOI: 10.1038/2041318a0. View

Reid W, STEFANO F, KURZEPA S, Brodie B . Tricyclic antidepressants: evidence for an intraneuronal site of action. Science. 1969; 164(3878):437-9. DOI: 10.1126/science.164.3878.437. View

Braestrup C, Nielsen M . Intra- and extraneuronal formation of the two major noradrenaline metabolites in the cns of rats. J Pharm Pharmacol. 1975; 27(6):413-9. DOI: 10.1111/j.2042-7158.1975.tb09470.x. View

Schubert J, Nyback H, Sedvall G . Effect of antidepressant drugs on accumulation and disappearance of monoamines formed in vivo from labelled precursors in mouse brain. J Pharm Pharmacol. 1970; 22(2):136-9. DOI: 10.1111/j.2042-7158.1970.tb08410.x. View

10.

Braestrup C, Andersen H, RANDRUP A . The monoamine oxidase B inhibitor deprenyl potentiates phenylethylamine behaviour in rats without inhibition of catecholamine metabolite formation. Eur J Pharmacol. 1975; 34(1):181-7. DOI: 10.1016/0014-2999(75)90238-1. View

11.

Braestrup C, Nielsen M, Scheel-Kruger J . Accumulation and disappearance of noradrenaline and its major metabolites synthesized from intraventricularly injected (3H)dopamine in the rat brain. J Neurochem. 1974; 23(3):569-78. DOI: 10.1111/j.1471-4159.1974.tb06061.x. View

12.

Schildkraut J, Roffman M, Orsulak P, Schatzberg A, Kling M, Reigle T . Effects of short-and long-term administration of tricyclic antidepressants and lithium on norepinephrine turnover in brain. Pharmakopsychiatr Neuropsychopharmakol. 1976; 9(4):193-202. DOI: 10.1055/s-0028-1094493. View

13.

Steinberg M, Smith C . Effects of desmethylimipramine and cocaine on the uptake, retention and metabolism of H3-tyramine in rat brain slices. J Pharmacol Exp Ther. 1970; 173(1):176-92. View

14.

Ceasar P, HAGUE P, SHARMAN D, WERDINIUS B . Studies on the metabolism of catecholamines in the central nervous system of the mouse. Br J Pharmacol. 1974; 51(2):187-95. PMC: 1776743. DOI: 10.1111/j.1476-5381.1974.tb09646.x. View

15.

Braestrup C . Identification of free and conjugated 3-methoxy-4-hydroxyphenylglycol (MOPEG) in rat brain by gas chromatography and mass fragmentography. Anal Biochem. 1973; 55(2):420-31. DOI: 10.1016/0003-2697(73)90132-2. View

16.

Nyback H, Walters J, Aghajanian G, Roth R . Tricyclic antidepressants: effects on the firing rate of brain noradrenergic neurons. Eur J Pharmacol. 1975; 32(02):302-12. DOI: 10.1016/0014-2999(75)90297-6. View

17.

Carlsson A, CORRODI H, Fuxe K, Hokfelt T . Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,alpha-dimethyl-meta-tyramine. Eur J Pharmacol. 1969; 5(4):367-73. DOI: 10.1016/0014-2999(69)90114-9. View

18.

. Differences between the effects of acute and long-term treatment with desmethylimipramine on reserpine-induced release of amines from rat brain. Biochem Pharmacol. 1975; 24(13-14):1321-5. DOI: 10.1016/0006-2952(75)90346-9. View

19.

Nielsen M, Eplov L, Scheel-Kruger J . The effect of amitriptyline, desipramine and imipramine on the vivo brain synthesis of 3H-noradrenaline from 3H-L-dopa in the rat. Psychopharmacologia. 1975; 41(3):249-54. DOI: 10.1007/BF00428932. View

20.

Nyback H, BORZECKI Z, Sedvall G . Accumulation and disappearance of catecholamines formed from tyrosine-14C in mouse brain; effect of some psychotropic drugs. Eur J Pharmacol. 1968; 4(4):395-403. DOI: 10.1016/0014-2999(68)90025-3. View